Four bellwether trials have been scheduled in the ongoing coordinated proceedings underway involving the blood-thinning medication Xarelto. The judge overseeing the coordination has put four trials on the calendar in the first half of 2017, which will provide valuable insight into how subsequent Xarelto lawsuits may be resolved. All of... Read more »

On August 7, 2015, five plaintiffs from as many states filed a joint complaint adding a Xarelto internal bleeding lawsuit to ongoing multi-district litigation (“MDL”). There are more than 500 Xarelto lawsuits already included in the MDL. The complex litigation is being overseen by U.S. District Judge Eldon Fallon in... Read more »

According to a recent study, Pradaxa and Xarelto bleeding complications may be no less prevalent than those associated with warfarin, an anticoagulant (blood thinner) that has been on the market for many years. The study contradicts some claims made about the newer drugs in terms of their overall safety and... Read more »

Thirteen plaintiffs have filed a lawsuit against multiple defendants, claiming that Xarelto, a blood-thinning medication, caused serious and sometimes fatal internal bleeding. The lawsuit names as defendants Janssen Research & Development LLC, Janssen Pharmaceuticals, Johnson & Johnson, and Bayer Healthcare Pharmaceuticals and demands that these parties be held accountable for... Read more »

A study recently published in the American Journal of Obstetrics & Gynecology (AJOG) found results indicating that the blood thinner Xarelto (rivaroxaban) crosses the placental barrier, raising questions about its safety for use in pregnant women. The study adds to concerns about Xarelto side effects that include serious bleeding problems... Read more »

Foreign regulators in Australia completed a review of a new class or oral anticoagulants – Xarelto, Pradaxa and Eliquis – finding little evidence to support the benefits of routine blood monitoring in patients. Prescriptions for these blood thinning medications have skyrocketed in recent years, primarily because of their dosing convenience, allowing... Read more »

The controversial blood thinning drug Xarelto has been named in yet another lawsuit – this time, tragically, following the death of an elderly Missouri resident who was prescribed the medication by his treating physician in December, 2012. Xarelto has been targeted with increasing scrutiny over the past several years, and... Read more »

A plaintiff from North Carolina has filed a Xarelto bleeding injury lawsuit over complications she claims stem from the drug’s lack of reversal agent and its manufacturer’s failure to provide adequate warning about this flaw. Tahkiya Daniels, of Halifax County, NC filed her complaint (Case 2:15-cv-01783) on May 28 in... Read more »

A plaintiff that filed a Xarelto lawsuit in Georgia alleges use of the drug led to life-threatening bleeding, permanent injury and loss of enjoyment of life. The plaintiff further states that Xarelto manufacturer Janssen Pharmaceuticals, as well as Janssen’s mother company Bayer, failed to provide proper warning about the risks... Read more »

Researchers at Johns Hopkins are suggesting that the use of two popular “new generation” blood thinners may run as much as twice the risk of gastrointestinal bleeding as the drug they are trying to replace. Despite recent research that has established that Pradaxa and Xarelto carry a significant increase in... Read more »